Advertisement
YOU ARE HERE: LAT HomeCollectionsRilutek Drug
IN THE NEWS

Rilutek Drug

FEATURED ARTICLES
BUSINESS
June 30, 1995 | Times Staff and Wire Reports
Rhone-Poulenc Seeks OK of Drug: The Collegeville, Pa.-based pharmaceutical company said it submitted a new-drug application to the Food and Drug Administration after two clinical trials showed Rilutek to be effective in treating Lou Gehrig's disease, technically known as amyotrophic lateral sclerosis, or ALS. The neuromuscular disease attacks nerve cells in the brain and spinal cord, resulting in muscle paralysis and respiratory failure.
ARTICLES BY DATE
BUSINESS
June 30, 1995 | Times Staff and Wire Reports
Rhone-Poulenc Seeks OK of Drug: The Collegeville, Pa.-based pharmaceutical company said it submitted a new-drug application to the Food and Drug Administration after two clinical trials showed Rilutek to be effective in treating Lou Gehrig's disease, technically known as amyotrophic lateral sclerosis, or ALS. The neuromuscular disease attacks nerve cells in the brain and spinal cord, resulting in muscle paralysis and respiratory failure.
Los Angeles Times Articles
|